Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In

Management Team

The Management Team is responsible for putting the company’s strategy into effect reviewing operations, human resources, strategy monitoring and R&D portfolio management.

William A. Hawkins III
President and CEO

Bill Hawkins was named President and CEO of Immucor in October 2011. Most recently, Bill was Chairman and Chief Executive Officer of Medtronic, Inc. He became Chief Executive Officer of Medtronic, Inc. in August 2007 and Chairman of the Board in August 2008. Mr. Hawkins was named President and Chief Operating Officer in May 2004 after joining Medtronic as Senior Vice President and President of Medtronic's Vascular business in January 2002. Mr. Hawkins joined Medtronic from Novoste Corp., where he had been President and Chief Executive Officer since 1998. Earlier positions included Corporate Vice President and President of the Sherwood Davis and Geck organization of American Home Products; President of the Ethicon Endo-Surgery organization of Johnson & Johnson; President, Devices for Vascular Intervention and President U.S. Operations, for Guidant Corp.; and several increasingly responsible executive positions culminating in the presidency of the IVAC organization for Eli Lilly & Co. He began his medical technology career with Carolina Medical Electronics in 1977. Mr. Hawkins received his Bachelor of Science degree in electrical and biomedical engineering from Duke University in 1976 where he also conducted medical research in pathology. He received a Master of Business Administration Degree from the Darden School of Business, University of Virginia, in 1982. Mr. Hawkins is a member of the Duke University Board of Trustees, the Board of Visitors of the Engineering School of Duke University and the Minneapolis Institute of Arts.




Dominique Petitgenet
Vice President, Chief Financial Officer

Dominique Petitgenet was named Vice President, Chief Financial Officer in March 2012. Before joining Immucor, Dominique was Chief Financial Officer of Merial, a worldwide leader in the animal health industry. A division of Sanofi, Merial had annual revenue of $2.6 billion in 2010 with sales in 150 countries. Prior to 2008, Mr. Petitgenet held a variety of positions with Merial including Corporate Controller. Prior to joining Merial in 2001, Mr. Petitgenet held various positions with Rhodia, Rhone-Poulenc Group and the Montedison Group. Mr. Petitgenet received a Masters in Finance from Paris Dauphine University.